Company News

Medmeme makes new senior sales appointment ACG Group appoints Richard Stedman as Group CEO Tetra Bio-Pharma appoints Bernard Fortier CEO Johnson Matthey turns 200 years old Chris Rombach joins ChargePoint aiding US expansion following multi-million-pound investment Surfachem appoints Dr Philip Wright as Strategic Business Development Manager The Royal Society announces Croonian Medallist 2018 Prof J Dressman joins Certara’s Simcyp Scientific Advisory Board Hubbard and Daikin united in commercial refrigeration TricorBraun announce new management positions Allied Minds subsidiary BridgeSat appoint Barry Matsumori CEO Cyclists Chiara Ricciardo and Riccardo Rocchi raise diabetes awareness Pharma companies still searching for answers on gender diversity Concept Life Sciences appoints Dr Andrew Clifton BioAscent appoints new CEO and plans to expand discovery services PharmaLex Group strengthens biosimilar expertise

Trending Articles

  1. Hansa Biopharma appoints Fredrik Röök as VP Business Development Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
  2. Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
  3. Alfa Laval appoints new managing director to drive strategic growth Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
  4. MHRA scientific leader recognised in 2026 King's Birthday Honours Dr Nicola Rose receives OBE for services to science and public health
  5. Aplagon appoints Carl Lindgren as Board Chair to guide later stage clinical and corporate development Veteran life sciences executive brings over 30 years of strategic and commercial leadership as Aplagon advances through Phase 2 development in multiple thrombosis-inflammatory diseases

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all